Ann Rheum Dis. Published Online First: 24 August 2007. doi:10.1136/ard.2007.076745
Review Article |
The B cell in systemic lupus erythematosus: a rational target for more effective therapy
1 Cedars-Sinai Medical Center, United States
* To whom correspondence should be addressed. E-mail: weisman{at}cshs.org.
Accepted 8 August 2007
Abstract
Current treatment options for systemic lupus erythematosus (SLE) are diverse and poorly defined, and aggressive therapy can be associated with serious toxicity and tolerability issues. There is, therefore, a need for new and improved treatments to be studied thoroughly in well-designed controlled trials. B-cell dysfunction has emerged as a key pathophysiological component of SLE and is a prime target for the development of new agents for a wide range of lupus severity, including advanced disease. Although many current drugs appear to modify B-cell function, the advent of new targeted therapies offers the hope of improved efficacy and a better long-term tolerability profile.
Keywords: B-cells, pathogenesis, systemic lupus erythematosus
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Ramos-Casals, M, Soto, M., Cuadrado, M., Khamashta, M.
(2009). Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases. Lupus
18: 767-776
[Abstract]
- Full Text (Rapid PDF)
-
All Versions of this Article:
ard.2007.076745v1
67/10/1374 most recent - Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
Citing Articles
Google Scholar
PubMed
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
